Follow
Wendy Stevens
Wendy Stevens
Other namesStevens Wendy S, Stevens W, StevensW.S.
University of the Witwatersrand and/or National Health Laboratory Ser
Verified email at wits.ac.za
Title
Cited by
Cited by
Year
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women
JM Baeten, D Donnell, P Ndase, NR Mugo, JD Campbell, J Wangisi, ...
New England journal of medicine 367 (5), 399-410, 2012
37072012
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
R Viana, S Moyo, DG Amoako, H Tegally, C Scheepers, CL Althaus, ...
Nature 603 (7902), 679-686, 2022
13752022
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
D Donnell, JM Baeten, J Kiarie, KK Thomas, W Stevens, CR Cohen, ...
The Lancet 375 (9731), 2092-2098, 2010
12422010
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study
N Wolter, W Jassat, S Walaza, R Welch, H Moultrie, M Groome, ...
The Lancet 399 (10323), 437-446, 2022
10132022
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
SE Dorman, SG Schumacher, D Alland, P Nabeta, DT Armstrong, B King, ...
The Lancet infectious diseases 18 (1), 76-84, 2018
6532018
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2
C Celum, A Wald, JR Lingappa, AS Magaret, RS Wang, N Mugo, ...
New England journal of medicine 362 (5), 427-439, 2010
6172010
Emergence of SARS-CoV-2 omicron lineages BA. 4 and BA. 5 in South Africa
H Tegally, M Moir, J Everatt, M Giovanetti, C Scheepers, E Wilkinson, ...
Nature medicine 28 (9), 1785-1790, 2022
5042022
HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study
RL Hamers, CL Wallis, C Kityo, M Siwale, K Mandaliya, F Conradie, ...
The Lancet infectious diseases 11 (10), 750-759, 2011
3432011
Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation
NT Funderburg, E Mayne, SF Sieg, R Asaad, W Jiang, M Kalinowska, ...
Blood, The Journal of the American Society of Hematology 115 (2), 161-167, 2010
3332010
Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial
I Sanne, C Orrell, MP Fox, F Conradie, P Ive, J Zeinecker, M Cornell, ...
The Lancet 376 (9734), 33-40, 2010
3032010
Xpert® MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope?
AV Rie, L Page-Shipp, L Scott, I Sanne, W Stevens
Expert review of molecular diagnostics 10 (7), 937-946, 2010
2972010
Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings
GG Sherman, G Stevens, SA Jones, P Horsfield, WS Stevens
JAIDS Journal of Acquired Immune Deficiency Syndromes 38 (5), 615-617, 2005
2542005
Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF
GJ Churchyard, WS Stevens, LD Mametja, KM McCarthy, V Chihota, ...
The Lancet Global Health 3 (8), e450-e457, 2015
2472015
Long-COVID: An evolving problem with an extensive impact
M Mendelson, J Nel, L Blumberg, SA Madhi, M Dryden, W Stevens, ...
South African Medical Journal 111 (1), 10-12, 2021
2392021
Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study
LE Scott, K McCarthy, N Gous, M Nduna, A Van Rie, I Sanne, WF Venter, ...
PLoS medicine 8 (7), e1001061, 2011
2352011
Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa
KCE Sigaloff, RL Hamers, CL Wallis, C Kityo, M Siwale, P Ive, ME Botes, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 58 (1), 23-31, 2011
2342011
Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a …
RL Hamers, R Schuurman, KCE Sigaloff, CL Wallis, C Kityo, M Siwale, ...
The Lancet infectious diseases 12 (4), 307-317, 2012
2312012
HIV-1 viral load assays for resource-limited settings
SA Fiscus, B Cheng, SM Crowe, L Demeter, C Jennings, V Miller, ...
PLoS medicine 3 (10), e417, 2006
2072006
CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa
E Karita, N Ketter, MA Price, K Kayitenkore, P Kaleebu, A Nanvubya, ...
PloS one 4 (2), e4401, 2009
2052009
The impact and cost of scaling up GeneXpert MTB/RIF in South Africa
G Meyer-Rath, K Schnippel, L Long, W MacLeod, I Sanne, W Stevens, ...
PloS one 7 (5), e36966, 2012
2022012
The system can't perform the operation now. Try again later.
Articles 1–20